Tomoyuki Saijo

ORCID: 0000-0001-9362-1516
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Treatment of Major Depression
  • Advanced MRI Techniques and Applications
  • Schizophrenia research and treatment
  • Neurotransmitter Receptor Influence on Behavior
  • Medical Imaging Techniques and Applications
  • Electroconvulsive Therapy Studies
  • Advanced Neuroimaging Techniques and Applications
  • Functional Brain Connectivity Studies
  • Nicotinic Acetylcholine Receptors Study
  • Pain Mechanisms and Treatments
  • Neuroscience and Neuropharmacology Research
  • Neurological disorders and treatments
  • EEG and Brain-Computer Interfaces
  • Cardiac Arrhythmias and Treatments
  • Garlic and Onion Studies
  • Spectroscopy Techniques in Biomedical and Chemical Research
  • Tryptophan and brain disorders
  • Genetic Neurodegenerative Diseases
  • Neurogenesis and neuroplasticity mechanisms
  • Neuropeptides and Animal Physiology
  • Optical Imaging and Spectroscopy Techniques
  • Cardiac Imaging and Diagnostics
  • Receptor Mechanisms and Signaling
  • Pharmacological Effects of Natural Compounds
  • Nerve injury and regeneration

Karolinska Institutet
2007-2020

Stockholm County Council
2017-2020

Stockholm Health Care Services
2017

Mitsubishi Group (Japan)
2014

Mitsubishi Tanabe Pharma Corporation
2014

Suzuki (Japan)
2014

Tohoku University
2014

Nippon Medical School
2009-2010

Tokyo Medical and Dental University
1998-2001

Chiba Rosai Hospital
2001

The human serotonin transporter (5-HTT) gene is one of the most extensively studied in psychiatry. A functional polymorphism promoter region 5-HTT (5-HTTLPR) has been associated with several psychiatric disorders as well anxiety-related personality traits. In search a mechanistic understanding implications 5-HTTLPR, influence this on regional 5-HT1A receptor density previously examined two positron emission tomography (PET) studies humans, yielding, however, contradictory results. present...

10.1017/s1461145708009759 article EN The International Journal of Neuropsychopharmacology 2009-01-06

10.1109/icce63647.2025.10929928 article EN 2023 IEEE International Conference on Consumer Electronics (ICCE) 2025-01-11

Article AbstractResults: There were no significant differences in D2 receptor binding between patients with MDD and controls. All 7 showed clinical improvements response to ECT treatment (P†‰<†‰.001). Significant changes binding, a mean of 25.2% reduction, found the right rostral anterior cingulate (AC) following

10.4088/jcp.08m04746blu article EN The Journal of Clinical Psychiatry 2009-12-15

In our previous positron emission tomography (PET) study, we demonstrated that ECT decreased dopamine D2 receptor in major depressive disorder (MDD). Although many animal studies have focused on the effect of serotonergic neurotransmission, no human study has directly examined brain serotonin [5-hydroxytryptamine (5-HT)] 1A receptors (5-HT1ARs). Using PET with [11C]WAY 100635, aimed to evaluate 5-HT1ARs patients MDD. Nine underwent scans before and after a series 6–7 bilateral ECTs....

10.1017/s1461145709991209 article EN The International Journal of Neuropsychopharmacology 2010-01-13

Background:Central substance P receptors, termed NK-1 have been considered as therapeutic targets in the development of drugs against diverse conditions, including emesis, overactive bladder, and depression.

10.1093/ijnp/pyu030 article EN cc-by-nc The International Journal of Neuropsychopharmacology 2014-10-31

Extrastriatal D2 dopamine receptors represent an important target of research into the pathophysiology and pharmacotherapy psychiatric disorders. The high affinity radioligand [11C]FLB 457 makes possible measurement low concentrations in extrastriatal regions using positron emission tomography (PET). aim this study was to assess test/retest variability reliability binding a reference tissue model. Eight healthy male subjects (aged 20-33 years) underwent two PET examinations. Radioactivity...

10.1097/00006231-200111000-00008 article EN Nuclear Medicine Communications 2001-11-01

Abstract Recent studies of the brain using magnetic resonance imaging (MRI) have suggested progressive structural changes in schizophrenics. However, those were conducted over periods less than 5 years and thus lacked sufficient capacity to determine course nature this process. In study, MRI scans obtained 15 schizophrenics 12 controls at baseline after 4‐ 10‐year follow ups. Volumes lateral ventricles measured. Patients assessed by Brief Psychiatric Rating Scale (BPRS) same two time points:...

10.1046/j.1440-1819.2001.00783.x article EN Psychiatry and Clinical Neurosciences 2001-02-01

The opioid antagonist naltrexone has been shown to attenuate the subjective effects of amphetamine. However, mechanisms behind this modulatory effect are currently unknown. We hypothesized that would diminish striatal dopamine release induced by amphetamine, which is considered an important mechanism many its stimulant properties. used positron emission tomography and D2-receptor radioligand [11C]raclopride in healthy subjects study dopaminergic amphetamine injection after pretreatment with...

10.1038/tp.2017.79 article EN cc-by-nc-nd Translational Psychiatry 2017-04-25

The aim of the study was to test: (i) if D2 /D3 binding in three functional subsections striatum is different patients with severe major depressive episodes than controls; and (ii) this difference normalized after electroconvulsive therapy (ECT).Nine inpatients were examined positron emission tomography (PET) radioligand [11 C]raclopride before an average 8.4 ECT sessions. Treatment response assessed using Montgomery-Åsberg Depression Rating Scale. Nine age- sex-matched controls twice PET...

10.1111/pcn.12980 article EN cc-by-nc Psychiatry and Clinical Neurosciences 2020-01-14

Abstract: Neuroleptics can induce not only physical adverse effects but also mental that produce deficit status in thought, affect, cognition, and behavior. This condition is known as neuroleptic-induced syndrome (NIDS), which includes apathy, lack of initiative, anhedonia, indifference, blunted reduced insight into disease. Although this old concept now appears almost forgotten, neuroleptics, whether typical or atypical, make depression bipolar disorder resemble other more refractory...

10.2147/ndt.s99577 article EN cc-by-nc Neuropsychiatric Disease and Treatment 2016-02-01

C-WAY 100635 has been used widely in the PET research field to measure 5-HT1A receptors living human brain. Reference tissue model analysis, which cerebellum was as reference tissue, employed clinical studies. However, reported binding potentials varied greatly among reports. In this study, regions of interest (ROIs) for were determined five different approaches six healthy male volunteers, and effects on potential parametric images compared.First, ROIs cerebellar cortex decided based...

10.1097/mnm.0b013e328013ebec article EN Nuclear Medicine Communications 2007-02-02

Evidence-based psychopharmacological algorithms for the treatment of patients with schizophrenia have been developed in many countries last decade. While it would be interest to consider a common algorithm based on international consensus, and information antipsychotics available each country are limited. Inspired by generated International Psychopharmacology Algorithm (IPA) Project, this has Japan Psychophamacology (JPA) Project. New antipsychotics, such as clozapine, olanzapine quetiapine,...

10.3109/13651509909068395 article EN International Journal of Psychiatry in Clinical Practice 1999-01-01

Functional neuroimaging techniques enable noninvasive measurements of cognitive functions in humans.We used functional to assess disturbance a patient with mild impairment.The was 58-year-old male memory disturbance, mini-mental state examination (MMSE) score 22! 30, and Clinical Dementia Rating Scale 0.5.On the Wechsler Adult Intelligence (WAIS-iii), intelligence quotient tests indicated total IQ=64, verbal IQ=71, performance IQ=61.The showed cortical atrophy on structural magnetic...

10.1272/jnms.77.188 article EN Journal of Nippon Medical School 2010-01-01
Coming Soon ...